Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sagar Lonial

Showing results (21-30 of 440) with videos related to

Pageof 44
Sort By:
Nature Reviews. Clinical Oncology|August 8, 2022
When an embarrassment of riches isn't enoughKrina Patel, Sagar Lonial
Oncology (Williston Park, N.Y.)|December 16, 2010
Melphalan or no melphalan: that is the questionJonathan Kaufman, Sagar Lonial
Hematology. American Society of Hematology. Education Program|January 18, 2011
Evidence-based mini-review: treatment options for patients with relapsed/refractory myeloma previously treated with novel agents and high-dose chemotherapy and autologous stem-cell transplantationNina Shah, Sagar Lonial
Hematology/Oncology Clinics of North America|September 13, 2014
Relapsed and refractory multiple myeloma: new therapeutic strategiesSilvia Gentili, Sagar Lonial
Biologics : Targets & Therapy|August 27, 2009
Clinical uses of GM-CSF, a critical appraisal and updateMartha Arellano, Sagar Lonial
Hematological Oncology|March 8, 2008
Review of peripheral neuropathy in plasma cell disordersJeannine Silberman, Sagar Lonial
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 29, 2025
A Cure, a Cure, My Kingdom for a Cure…Sagar Lonial, Shaji Kumar
Blood|May 17, 2014
Down to the bitter endSagar Lonial, Charise Gleason
Oncology (Williston Park, N.Y.)|May 30, 2009
Treatment of multiple myeloma: whence truth over belief?Jonathan Kaufman, Sagar Lonial
British Journal of Haematology|April 7, 2009
Emerging combination treatment strategies containing novel agents in newly diagnosed multiple myelomaSagar Lonial, Jamie Cavenagh
Pageof 44

Showing results (21-30 of 440) with videos related to

Sort By:
Pageof 44
Nature Reviews. Clinical Oncology|August 8, 2022
When an embarrassment of riches isn't enoughKrina Patel, Sagar Lonial
Oncology (Williston Park, N.Y.)|December 16, 2010
Melphalan or no melphalan: that is the questionJonathan Kaufman, Sagar Lonial
Hematology. American Society of Hematology. Education Program|January 18, 2011
Evidence-based mini-review: treatment options for patients with relapsed/refractory myeloma previously treated with novel agents and high-dose chemotherapy and autologous stem-cell transplantationNina Shah, Sagar Lonial
Hematology/Oncology Clinics of North America|September 13, 2014
Relapsed and refractory multiple myeloma: new therapeutic strategiesSilvia Gentili, Sagar Lonial
Biologics : Targets & Therapy|August 27, 2009
Clinical uses of GM-CSF, a critical appraisal and updateMartha Arellano, Sagar Lonial
Hematological Oncology|March 8, 2008
Review of peripheral neuropathy in plasma cell disordersJeannine Silberman, Sagar Lonial
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 29, 2025
A Cure, a Cure, My Kingdom for a Cure…Sagar Lonial, Shaji Kumar
Blood|May 17, 2014
Down to the bitter endSagar Lonial, Charise Gleason
Oncology (Williston Park, N.Y.)|May 30, 2009
Treatment of multiple myeloma: whence truth over belief?Jonathan Kaufman, Sagar Lonial
British Journal of Haematology|April 7, 2009
Emerging combination treatment strategies containing novel agents in newly diagnosed multiple myelomaSagar Lonial, Jamie Cavenagh
Pageof 44